LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

277.44 0.98

Rezumat

Modificarea prețului

24h

Curent

Minim

272.21

Maxim

277.51

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

40.664

78.892

EPS

1.96

Randament dividend

0.31

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+25.66% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.31%

2.38%

Data viitoare de dividende

4 feb. 2026

Următoarea dată ex-dividende

28 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

9.2M

20B

Deschiderea anterioară

276.46

Închiderea anterioară

277.44

Sentimentul știrilor

By Acuity

34%

66%

92 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 dec. 2025, 15:21 UTC

Câștiguri

Correction to Home Depot Outlook Headline on Dec. 9

23 dec. 2025, 23:54 UTC

Market Talk

Gold Climbs Above $4,500/oz for First Time Amid Rising Geopolitical Tensions -- Market Talk

23 dec. 2025, 23:40 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

23 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 dec. 2025, 21:21 UTC

Achiziții, Fuziuni, Preluări

St Barbara to Use Deposit Toward A$370 Million Subscription to Buy 50% of Simberi Unit

23 dec. 2025, 21:20 UTC

Achiziții, Fuziuni, Preluări

St Barbara to Hold Deposit in Escrow

23 dec. 2025, 21:20 UTC

Achiziții, Fuziuni, Preluări

St Barbara: Deposit Represents Progress on Lingbao's Strategic Investment in Simberi Mine

23 dec. 2025, 21:19 UTC

Achiziții, Fuziuni, Preluări

St Barbara Receives A$32 Million Deposit From Lingbao Gold

23 dec. 2025, 21:13 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Bets on Cybersecurity to Boost Growth -- Analysis

23 dec. 2025, 20:16 UTC

Market Talk

Oil Futures Settle Higher on Geopolitical Tensions -- Market Talk

23 dec. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Soars on Colder Weather Outlook -- Market Talk

23 dec. 2025, 19:13 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Mergers and Acquisitions Soared This Year. 2026 Could Be Even Bigger. -- Barrons.com

23 dec. 2025, 18:58 UTC

Market Talk

Gold Has Another Record-Setting Day -- Market Talk

23 dec. 2025, 18:32 UTC

Market Talk

U.S. Oil Rig Count Rises By 3 to 409 -- Market Talk

23 dec. 2025, 17:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

23 dec. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

23 dec. 2025, 17:09 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Armis Seen as Good Fit for ServiceNow in $7.8B Deal -- Market Talk

23 dec. 2025, 16:21 UTC

Market Talk

Monthly Canadian GDP Points to Flat Activity So Far for 4Q -- Market Talk

23 dec. 2025, 16:16 UTC

Market Talk

Recent 'Disorderly' Yen Falls Could Justify Intervention -- Market Talk

23 dec. 2025, 16:15 UTC

Market Talk

Precious Metals Pare Gains -- Market Talk

23 dec. 2025, 16:03 UTC

Achiziții, Fuziuni, Preluări

Erste Group Bank: Closing Expected Around Mid-January

23 dec. 2025, 16:03 UTC

Achiziții, Fuziuni, Preluări

Erste Group Bank Also Obtained Regulatory Approvals for 50% Stake in Santander Towarzystwo Funduszy Inwestycyjnych

23 dec. 2025, 16:02 UTC

Achiziții, Fuziuni, Preluări

Erste Group Bank Obtained Regulatory Approvals by Polish Regulator KNF for Acquisition of Roughly 49% Controlling Stake in Santander Bank Polska

23 dec. 2025, 16:01 UTC

Achiziții, Fuziuni, Preluări

Erste Group Bank Receives Green Light for Acquisition in Poland

23 dec. 2025, 15:42 UTC

Achiziții, Fuziuni, Preluări

Telefonica: Agreement is For Sale of Telefonica Tech Business in Colombia, Mexico, Chile

23 dec. 2025, 15:42 UTC

Achiziții, Fuziuni, Preluări

Telefonica Doesn't Set Out Financial Details of Divestment

23 dec. 2025, 15:41 UTC

Achiziții, Fuziuni, Preluări

Telefonica: Deal Will Allow Focus on Core Markets

23 dec. 2025, 15:40 UTC

Achiziții, Fuziuni, Preluări

Telefonica To Sell Telefonica Tech South American Business to Hiberus

23 dec. 2025, 15:19 UTC

Market Talk

Fixed-Income Traders Misread Underlying Strength of Canada Economy -- Market Talk

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

25.66% sus

Prognoză pe 12 luni

Medie 348.7 USD  25.66%

Maxim 375 USD

Minim 285 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

10

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

92 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat